Ketki Tendulkar

852 total citations
22 papers, 645 citations indexed

About

Ketki Tendulkar is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Ketki Tendulkar has authored 22 papers receiving a total of 645 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 8 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Ketki Tendulkar's work include Sarcoma Diagnosis and Treatment (4 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Angiogenesis and VEGF in Cancer (3 papers). Ketki Tendulkar is often cited by papers focused on Sarcoma Diagnosis and Treatment (4 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Angiogenesis and VEGF in Cancer (3 papers). Ketki Tendulkar collaborates with scholars based in United States, India and Australia. Ketki Tendulkar's co-authors include Apar Kishor Ganti, Anil Potti, Amit Panwalkar, Abe E. Sahmoun, Michael O. Koch, Vijaya Raj Bhatt, Mohsin Mirza, Archana Laroia, Kirk Foster and Prajwal Dhakal and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Journal of the American Society of Nephrology.

In The Last Decade

Ketki Tendulkar

21 papers receiving 625 citations

Peers

Ketki Tendulkar

ONCOL

PRM

GENET

EPIDE

Frank Peters Netherlands

Akthar Shamsaldin France

C. Bokemeyer Germany

Michelle Afkhami United States

C.G. Alexopoulos Greece

Xiaochen Shu China

Jennifer Herring United States

Marcella Occelli Italy

Marija Bojić Austria

Jonathan C. Yau United States

Frank Peters Netherlands

Ketki Tendulkar

425 ×1.2

ONCOL

323 ×1.2

PRM

76 ×0.5

60 ×0.8

GENET

61 ×0.8

EPIDE

Citations per year, relative to Ketki Tendulkar Ketki Tendulkar (= 1×) peers Frank Peters

Countries citing papers authored by Ketki Tendulkar

Since Specialization

Citations

This map shows the geographic impact of Ketki Tendulkar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ketki Tendulkar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ketki Tendulkar more than expected).

Fields of papers citing papers by Ketki Tendulkar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ketki Tendulkar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ketki Tendulkar. The network helps show where Ketki Tendulkar may publish in the future.

Co-authorship network of co-authors of Ketki Tendulkar

This figure shows the co-authorship network connecting the top 25 collaborators of Ketki Tendulkar. A scholar is included among the top collaborators of Ketki Tendulkar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ketki Tendulkar. Ketki Tendulkar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tendulkar, Ketki, et al.. (2022). Risk of malignancy in patients with chronic kidney disease. PLoS ONE. 17(8). e0272910–e0272910. 10 indexed citations

Foster, Kirk, et al.. (2022). Immunotherapy-Induced Glomerulonephritis: Whodunit?. Journal of the American Society of Nephrology. 33(11S). 381–381. 1 indexed citations

Shostrom, Valerie, et al.. (2021). Hepatitis B Vaccination in Advanced Chronic Kidney Disease: A Quality Improvement Project at a Veteran Affairs Chronic Kidney Disease Clinic. Infectious Disease Reports. 13(4). 1036–1042. 7 indexed citations

Tendulkar, Ketki, et al.. (2018). Fortuitous benefits of living kidney donation: Diagnosis of serious medical conditions during the living donor evaluation. Clinical Transplantation. 32(3). e13204–e13204. 5 indexed citations

Foster, Kirk, et al.. (2017). Detection and Treatment of Monoclonal Gammopathy of Renal Significance With Progression to Light Chain Deposition Disease. Journal of Oncology Practice. 13(10). 707–708. 2 indexed citations

Mirza, Mohsin, et al.. (2015). Renal Toxicities of Targeted Therapies. Targeted Oncology. 10(4). 487–499. 65 indexed citations

Bhatt, Vijaya Raj, et al.. (2014). Ipilimumab-Induced Hypophysitis and Uveitis in a Patient With Metastatic Melanoma and a History of Ipilimumab-Induced Skin Rash. Journal of the National Comprehensive Cancer Network. 12(8). 1077–1081. 59 indexed citations

Tendulkar, Ketki, Audrey J. Lazenby, & Gerald C. Groggel. (2010). Rapid onset metastatic pulmonary calcifications in end‐stage renal disease. Dialysis & Transplantation. 39(3). 109–111.

Ganti, Apar Kishor, Abe E. Sahmoun, Amit Panwalkar, Ketki Tendulkar, & Anil Potti. (2005). Hormone Replacement Therapy Is Associated With Decreased Survival in Women With Lung Cancer. Journal of Clinical Oncology. 24(1). 59–63. 154 indexed citations

10.

Potti, Anil, et al.. (2004). Immunohistochemical detection of HER-2/neu, c-kit (CD117) and vascular endothelial growth factor (VEGF) overexpression in soft tissue sarcomas.. PubMed. 24(1). 333–7. 30 indexed citations

11.

Potti, Anil, et al.. (2004). Role of HER-2/neu Overexpression and Clinical Features at Presentation as Predictive Factors in Meningiomas. American Journal of Clinical Oncology. 27(5). 452–456. 17 indexed citations

12.

Potti, Anil, et al.. (2004). Immunohistochemical determination of HER-2/neu, c-Kit (CD117), and vascular endothelial growth factor (VEGF) overexpression in malignant melanoma. Journal of Cancer Research and Clinical Oncology. 130(2). 80–86. 32 indexed citations

13.

Potti, Anil, et al.. (2004). Determination of vascular endothelial growth factor (VEGF) overexpression in soft tissue sarcomas and the role of overexpression in leiomyosarcoma. Journal of Cancer Research and Clinical Oncology. 130(1). 52–56. 75 indexed citations

14.

Potti, Anil, et al.. (2004). Immunohistochemical determination of vascular endothelial growth factor (VEGF) overexpression in malignant melanoma.. PubMed. 23(5A). 4023–6. 16 indexed citations

15.

Ganti, Apar Kishor, et al.. (2003). Predictive value of absent bone marrow iron stores in the clinical diagnosis of iron deficiency anemia.. PubMed. 17(5). 389–92. 23 indexed citations

16.

Potti, Anil, et al.. (2003). HER-2/neu and CD117 (C-kit) overexpression in hepatocellular and pancreatic carcinoma.. PubMed. 23(3B). 2671–4. 33 indexed citations

17.

Ganti, Apar Kishor, et al.. (2003). HER-2/neu Overexpression detected by Immunohistochemistry in Soft Tissue Sarcomas. American Journal of Clinical Oncology. 26(2). 188–191. 12 indexed citations

18.

Ganti, Apar Kishor, et al.. (2003). Endothelium and the lipid metabolism: the current understanding. International Journal of Cardiology. 88(1). 1–9. 41 indexed citations

19.

Ganti, Apar Kishor, et al.. (2003). HER-2/neu Overexpression detected by Immunohistochemistry in Soft Tissue Sarcomas. American Journal of Clinical Oncology. 26(2). 188–191. 5 indexed citations

20.

Ganti, Apar Kishor, Anil Potti, Michael Koch, et al.. (2002). Predictive Value of Clinical Features at Initial Presentation in Pancreatic Adenocarcinoma : A Series of 308 Cases. Medical Oncology. 19(4). 233–238. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact